Addressing Clinicians’ Challenges and Misinformation Around New and Emerging Treatments for Alzheimer Disease

<p>Credits: 0.25 AMA PRA Category 1 Credit™</p> <p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/alzheimer-disease-addressing-challenges-pt2'>https://www.pri-med.com/online-education/podcast/alzheimer-disease-addressing-challenges-pt2</a></p> <p>Overview: Alzheimer disease (AD) treatment is evolving. With this rapid expansion in potential therapies, there remain challenges and misconceptions. Join neurologist Gad Marshall, MD in this two-part podcast series, as he answers important questions about new and emerging disease-modifying therapies and explores ways in which these treatments may be considered in the future for patients. </p> <p>The topics covered in this podcast are based on challenges and misconceptions identified from the CME/CE curriculum The Future of Alzheimer Disease: <a href='https://www.pri-med.com/online-education/curriculum/future-of-alzheimer-disease'>Early Recognition and Emerging Therapy</a>.</p>